CCM
ESPR

Chicago Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Chicago Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
+830,935
New +$2.32M 2.32% 19

Other funds holding ESPR

TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CIAS
CFS Investment Advisory Services Totowa, New Jersey $1.5B AUM 20.41% 1-Year Est. Return

Chicago Capital Management's ESPR Position: Q2 2026 in Review

Chicago Capital Management opened a new position in Esperion Therapeutics (ESPR) in Q2 2026: 830,935 shares worth $2.61M. The stake represents 2.32% of the portfolio and ranks #19 among its holdings.

26 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • Chicago Capital Management held 830,935 shares of Esperion Therapeutics worth $2.61M as of Q2 2026.
  • Esperion Therapeutics was a new Chicago Capital Management position in Q2 2026.
  • Esperion Therapeutics made up 2.32% of Chicago Capital Management's portfolio in Q2 2026, its #19 holding.
  • 26 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Chicago Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.